health
By Emma Farge, Jennifer Rigby, Olivia Le Poidevin and Aaron Ross
NAIROBI/LONDON/GENEVA, June 9 (Reuters) – Nearly a month into one of the world’s largest ever Ebola outbreaks, medics in eastern Democratic Republic of Congo are struggling to secure basic equipment to stay safe and prevent further spread of the...
Read More
Berlin hospital discharges US doctor who contracted Ebola
By Milana Vinn
NEW YORK, June 6 (Reuters) – A U.S. citizen treated in Germany after contracting Ebola in the Democratic Republic of Congo has been discharged, a Berlin hospital said on Saturday.
• No virus has been detected in the patient since May 30, the Charité...
Read More
Accessorize with earplugs at this summer’s concerts so you can enjoy more music in the future
NEW YORK (AP) — When her favorite band took the stage, Kristin Shires was in the front row.
As the Misterwives started to play, the drums and saxophones blared from the trembling speakers. Shires soaked in the music — but on the way home, a different sound played in her...
Read More
health Headlines
Trump administration warns more than 500 hospitals to provide more price information or face fines- FDA expands sunscreen options with first new ingredient since 1990s
- India’s Ajanta Pharma promoter sells stake worth about 10.24 billion rupees
- Playing hip-hop or Doris Day, older exercise instructors can speak their peers’ language
- Three more US passengers from hantavirus-hit ship return to home states
- A government-commissioned study found drinking risks. US guidelines didn’t feature its findings
- Europe faces growing synthetic opioids risks as drug market evolves, EU agency warns
- Cholera outbreak in Nigeria’s Borno kills 74, infects thousands since May
- Congo Ebola contact tracing is below target but has improved, WHO says
- Parabilis Medicines targets $2.3 billion valuation in upsized US IPO
- Cancer vaccines based on mRNA advance, despite US cuts
- Indian cancer patients battle shortage of key drugs as platinum costs surge
- UK reviewing Palantir’s NHS contract amid pressure to use break clause
- Highly effective prevention drug arrives in South Africa, which has world’s highest HIV burden
- Congo’s Ebola outbreak rises to over 100 deaths out of 550 cases as conflict slows response
- Roche sticks to German investment after Eli Lilly cuts
- Survivors share experiences and lessons from Congo’s 2018 Ebola outbreak
- AlzeCure signs collaboration, out-licensing deal with Lilly for Alzheimer’s drug
- GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
- Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests
- Congo says Ebola deaths top 100 as armed groups threaten response
- AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
- Gavi plans to use U.S. cash for malaria, while meeting Kennedy’s conditions
- A flesh-eating cattle parasite spreads beyond Texas as new screwworm cases are found
- WHO’s Tedros says Uganda should reconsider Congo border closure over Ebola
- How to stay safe while traveling during extreme heat
- How the Ebola outbreak is changing weddings in Congo
- Ukrainian mothers see a rising number of complications with their pregnancies, in photos
- Tango Therapeutics’ pancreatic cancer drug combo shows promise in study
- Incyte makes $2 billion bet on bleeding disorder drug ahead of Jakafi patent cliff
- Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
- US FDA approves Pfizer’s bleeding disorder drug for children
- Health experts to screen US wastewater for disease outbreaks during World Cup
- Roche enters cancer drug deal worth up to $2.3 billion with Nurix Therapeutics
- Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial
- As Ukraine fights off Russia’s invasion, some regions see a rise in premature births
- Australian cancer specialist Richard Scolyer dies at 59 after pioneering treatment
- Congo says number of confirmed Ebola cases rises to 515
- Boehringer-Zealand’s obesity drug shows promise in cutting visceral, liver fat
- Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports
- Swiss firms invest $27 billion in US after tariff deal, NZZ am Sonntag reports
- Palestinians suffer from lack of proper toilets across Gaza’s vast tent cities
- Dexcom’s glucose monitor use shows benefit in non-insulin diabetic patients in study
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits
- Pfizer’s monthly obesity shot has side-effect profile similar to Wegovy in midstage trial
- Screwworm border closure fuels beef boom in Mexico, gloom in Texas
- Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial
- Texas governor wants to speed up work on a fly-breeding factory to fight a cattle parasite
- Ebola outbreak in Central Africa could reach 20,000 cases without strong public health measures
